LCI 1367
Pill imprint LCI 1367 has been identified as Probenecid 500 mg.
Probenecid is used in the treatment of gout; adjunct to antibiotic therapy and belongs to the drug class antigout agents. FDA has not classified the drug for risk during pregnancy.
Probenecid 500 mg is not subject to the Controlled Substances Act.
See also related documents.
Probenecid Images
- Imprint:
-
LCI
1367 - Strength:
- 500 mg
- Color:
- Yellow
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- microcrystalline cellulose
sodium lauryl sulfate
sodium starch glycolate type A potato
corn starch
povidone k29/32
silicon dioxide colloidal
magnesium stearate
polyvinyl alcohol
titanium dioxide
polyethylene glycol
magnesium silicate
D&C Yellow No. 10
FD&C Yellow No. 6
FD&C Blue No. 2
aluminum oxide
- Drug Class:
- Antigout agents
- Pregnancy Category:
- N - Not yet classified
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Lannett Company, Inc.
- National Drug Code (NDC):
- 00527-1367
More Probenecid resources
- Probenecid (Wolters Kluwer)
- probenecid (Cerner Multum)
- Probalan (Micromedex) - Includes Dosage Information
- probenecid (Micromedex) - Includes Dosage Information
- Probenecid (AHFS DI)
- Probenecid (FDA)
- Probenecid Tablets (FDA)
- Probenecid (Wolters Kluwer)


